Qianju Enterprise Management

TrialOS, legally known as Shanghai Qianju Enterprise Management Consulting, is a leading digital clinical trial service platform in China, commonly known as Yaoyanshe. Founded in 2015, the company provides a full-stack solution for clinical research, including site selection, patient recruitment, and data management through its proprietary TrialOS platform. The company utilizes a 'platform + service' model to connect pharmaceutical enterprises, hospitals, and contract research organizations to improve the efficiency of drug development. TrialOS has secured significant funding from major investors like Sequoia China and Matrix Partners to expand its digital infrastructure and clinical service capabilities.